Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/14/22
End: 02/27/24
Due: 02/27/25
Phase: N/A
Priority: Normal
Start: 04/20/21
End: 12/13/22
Due: 12/13/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Open-label Extension Study of ADP101 | NCT05243719 | Alladapt Immunotherapeutics, Inc. | user2@example.com | None | 2022-03-14 | 2024-02-27 | 2025-02-27 | - | - | 2025-07-14 |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults | NCT04856865 | Alladapt Immunotherapeutics, Inc. | user2@example.com | None | 2021-04-20 | 2022-12-13 | 2023-12-13 | - | - | 2025-07-14 |